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Abstract Human body fluids such as blood and saliva
represent the most common source of biological material
found at a crime scene. Reliable tissue identification in
forensic science can reveal significant insights into crime
scene reconstruction and can thus contribute toward solving
crimes. Limitations of existing presumptive tests for body
fluid identification in forensics, which are usually based on
chemoluminescence or protein analysis, are expected to be
overcomeby RNA-based methods, provided that stableRNA
markerswithtissue-specificexpressionpatternsareavailable.
To generate sets of stable RNA markers for reliable
identification of blood and saliva stains we (1) performed
whole-genome gene expression analyses on a series of time-
wise degraded blood and saliva stain samples using the
Affymetrix U133 plus2 GeneChip, (2) consulted expression
databases to obtain additional information on tissue specific-
ity, and (3) confirmed expression patterns of the most
promising candidate genes by quantitative real-time poly-
merase chain reaction including additional forensically
relevant tissues such as semen and vaginal secretion. Overall,
we identified nine stable mRNA markers for blood and five
stable mRNA markers for saliva detection showing tissue-
specific expression signals in stains aged up to 180 days of
age, expectedly older. Although, all of the markers were able
to differentiate blood/saliva from semen samples, none of
them could differentiate vaginal secretion because of the
complex nature of vaginal secretion and the biological
similarity of buccal and vaginal mucosa. We propose the
use of these 14 stable mRNA markers for identification of
blood and saliva stains in future forensic practice.
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Introduction
Human body fluids such as blood and saliva are the most
common sources of biological trace material found at a crime
scene. Reliable tissue identification in forensic casework is
important as it provides crucial insights into crime scene
reconstruction and can thus contribute towards solving
crimes. Blood stains are routinely tested in forensic practise
using various methods including the tetrabase (4,4-bis
(dimethylamino)diphenylmethane) test [1], the Kastle–
Meyer phenolphthalein test, the tetramethylbenzidine test
[2], the orthotolidine test [3], or the luminol (3-aminoph-
thalhydrazide) chemoluminescence test [4], with the latter
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cleaning attempts [2, 5]. All these presumptive—thus
indicative but not identifying—tests take advantage of the
peroxidase-like activity of the heme unit of the hemoglobin
molecule in human blood. Therefore, false-positive results
can be caused by the presence of strong oxidants, such as
chlorine-containing detergents or by true peroxidases (e.g.,
from plants) [6].
Saliva stains are usually detected in forensic practise via
an enzymatic amylase test using Phadebas [7] or with a
recently developed enzyme-linked immunosorbent assay-
based method [8]. However, because of amylase degrada-
tion, the time window for the successful performance of such
tests can be limited [9]. Furthermore, no amylase assay can
distinguish between salivary amylase and amylases from
other tissues (pancreatic, urinary, etc.); therefore, the tests
for saliva identification are only presumptive (similar to
existing blood identification tests).
On the other hand, methods for identification and
quantification of mRNA are already well established,
although mostly outside the forensic field. These methods
make massive multiplex gene expression profiling possible—
among many other applications—for the discovery of
tissue-specific mRNA markers. The major concern of using
mRNA markers for forensic applications is their assumed
high susceptibility to degradation. However, recent studies
using a few selected genes demonstrated that it is possible to
isolate total RNA of sufficient quality and quantity from
biological stains that are several months or even years old
[10–12]. It has also been suggested, although with limited
evidence so far, that different types of mRNA seem to
follow different rates of degradation [13]. It is assumed that
the degradation process of mRNA is influenced by many
external and internal factors, including structural peculiarities
like the presence of AU-rich elements (ARE motifs), protein
binding properties, and cellular localization [14, 15].
However, detailed knowledge on the molecular reasons for
differences in RNA degradation between different types of
RNAs as well as between mRNAs of different genes is cur-
rently lacking and further investigations are sorely needed.
Although a small number of mRNA markers has been
tested for tissue identification in forensic science [16–19],
no systematic study has yet been performed. In addition,
the identification of candidate markers in previous studies
was based on a mixed literature and database search,
apparently without strict criteria of selection, considering
only a limited number of genes and tissues, and not taking
into account RNA degradation levels. Furthermore, ex-
pressed sequence tags databases, which were used previ-
ously, like the Cancer Genome Anatomy Project [18], are
expected to provide heavily biased information on candi-
date genes because of the nonrandom character of repre-
sentation of clone libraries.
To find stable mRNA markers for body fluid identifica-
tion in forensic practice, we performed a systematic and
comprehensive whole-genome gene expression analysis on
time-wise degraded blood and saliva stains using the
Affymetrix U133 plus2 GeneChip. This expression array
contains >54,000 mRNA probe sets, which encompass
most, if not all, known and predicted human genes. Tissue-
specific expression patterns of the most promising candi-
date genes from the array analyses were further confirmed
using the GNF SymAtlas expression database [20], which
covers about 100 human tissues, and finally verified by
quantitative real-time polymerase chain reaction (PCR) in
blood and saliva as well as in other body fluids relevant for
forensic casework, i.e., semen and vaginal secretion.
Materials and methods
Sample collection
Aliquots of 5 ml of whole blood and saliva were collected
from each of five healthy volunteers (four men and one
woman) of western European genetic origin under informed
consent before their inclusion in the study. Native blood
was collected without anticoagulation treatment to avoid
disturbing effects of anticoagulation reagents on gene
expression. In each sample, 75 cotton swabs were im-
mersed. Special care was taken to shorten the time between
collection and swab absorption to avoid blood coagulation.
After complete absorption of the fluids, swabs were left
until dry on a bench top at room temperature. When dry, the
swabs were stored in dust-free nonhumid conditions (but
subjected to normal daylight) for different time intervals.
Swabs were visually inspected and sorted out to ensure
similar liquid content between individual swabs. After 0, 1,
3, 7, 14, 21, 57, and 180 days, swabs were stored at −80°C
until RNA isolation. For the time interval 0 days, samples
were frozen immediately after drying. Semen and vaginal
secretion samples were collected from one male and one
female individual absorbed with cotton swabs and dried
overnight before RNA isolation.
RNA isolation
RNA was isolated using the Qiagen RNeasy kit (Qiagen
Benelux B.V.) according to the manufacturer’s instructions
with minor modifications. These included cutting up the
cotton swab into 1×1-mm pieces and soaking them in RLT
buffer for 1 h at 4°C before the extraction. Trial experi-
ments to lengthen this incubation time up to 24 h did not
reveal any improvement in respect to RNA quantity and
quality (data not shown).
136 Int J Legal Med (2008) 122:135–142Microarray hybridization and gene expression data analysis
Before hybridization to Affymetrix U133 plus2.0 GeneChip
arrays (Affymetrix, Santa Clara, CA), RNA isolated from
blood and saliva stains was amplified using the Ambion
MEGAscript T7 two-cycle amplification kit (Applied
Biosystems, The Netherlands). Amplification, labeling,
hybridization, washing, and scanning were performed by
the microarray core facility of the Erasmus MC Center for
Biomics according to Affymetrix specifications. Back-
ground subtraction and probe signal summarization were
calculated according to the robust multiarray analysis
algorithm [21] using the R Bioconductor software [22];
the resulting log2 signal values were back-transformed to
linear scale. Presence/absence calls for individual probe sets
were calculated with the mas5calls function of the
Bioconductor mas package. Because the constant global
mean assumption does not hold true for arrays hybridized
to differentially degraded RNA samples, the normalization
of the signal intensities between samples was performed
using the nonhuman control genes present on Affymetrix
arrays (spiked-in probes). Normalization factors for each
array were inferred from the average signal intensities of
bioB, bioC, bioD, and Cre control probe sets. Analysis of
differential gene expression was performed using the
significance analysis of microarrays (SAM) algorithm [23]
implemented in the TM4 software [24]. In the saliva
dataset, we selected only genes with signal intensities
above 50 (which is below the usually applied background
threshold in expression array experiments) that had a signal
intensity below 50 in the blood dataset. The selection of
blood-targeted genes was done in a similar manner but with
different criteria, the lower intensity limit in blood was set
to 1,000 to reasonably restrict the number of candidates.
Real-time PCR
First strand cDNAs were synthesized with SuperScript® III
RTS First-Strand cDNA Synthesis Kit (Invitrogen BV, The
Netherlands) using total RNA as a template. The primers
were designed with Primer3 software [25] so that forward
and reverse primers were complementary to different exons
of the respective genes and most closely located to the 3′-
end of the corresponding RefSeq cDNA (Electronic
Supplementary Material Table S1). Real-time PCR reac-
tions with the SuperScript® III Platinum® SYBR® Green
One-Step qPCR Kit (Invitrogen BV) were performed on an
ABI 7300 PCR machine (Applied Biosystems, The Nether-
lands) using the following parameters: initial denaturation
at 94°C for 10 min, followed by 45 cycles of denaturation
at 94°C for 15 s, and a final annealing/elongation at 60°C
for 30 s. Melting profiling and agarose gel electrophoresis
were used to confirm the specificity of the primers and the
absence of DNA contamination. Quantification of the
amplified cDNA yield in comparative blood and saliva
PCRs was done by the standard curve method. PCR
experiments with semen and vaginal secretion were
quantified using delta Ct (dCt) method. In both cases,
GAPDH gene was used as an endogenous control to
normalize the amplification signal between the samples
from different tissues and individuals. Time points were
compared to each other without normalization: Assuming
the temporal degradation of all RNA molecules, no internal
control gene could be used, and the only proper way to
normalize RT-PCR signals was to use the same amount of
template in each reaction. We found that this requirement
holds true for our experiments because the GAPDH
expression variability between different samples from the
same tissue was relatively low (CV <25%, data not shown),
which is probably because of approximately the same
amount of blood or saliva absorbed with cotton swabs
during material collection.
Results and discussion
Microarray expression data
As expected, hybridization signals demonstrated high
variability between individuals; however, the most striking
differences were observed between the different tissues.
Signal intensities in blood samples were on average about
five times higher than in saliva (174.2±1.9 in blood
samples vs 26.9±0.7 in saliva; Wilcoxon test rank sum p<
0.001). In addition, at the time-point zero, the number of the
probe sets called as present according to the Affymetrix
algorithm was, on average, more than three times higher in
blood than in saliva (30.2%±0.9 vs 9.3%±0.6; t test p<
0.001). The SAM test with stringent parameters (false
discovery rate was set to 0%) showed that, both in blood
and saliva experiments, no genes demonstrated significant
expression differences in a time range of 0–57 days of stain
storage. Only few genes (37 and 10 significantly differential
genes for saliva and blood, respectively) appeared to be
differentially expressed at 180 days in comparison to other
time points. This suggests that in dried blood and saliva,
mRNA molecules remain relatively stable for a long period.
Recent studies of Heinrich et al. [26] also revealed poor
correlation between RNA degradation and postmortem time
intervals.
Selection of tissue-specific markers
The initial selection of tissue-specific genes was performed
using the normalized signal intensities of microarray
hybridizations averaged across the five biological replicates
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saliva-specific and 1,000 apparent blood-specific candidate
genes were selected. Further refinement of tissue-specific
gene sets was achieved by probing the selected candidates
against the GNF SymAtlas tissue database [20]a f t e r
excluding all cell lines from the database retaining only
tissues and organs for the analysis. Genes were selected
only if they were highly and exclusively expressed in the
target tissue(s) based on the GNF SymAtlas database. For
blood, target tissue in the database was defined as whole
blood; while for saliva, the target tissues were salivary
gland, tongue, trachea, and tonsils. The selection criteria
were as follows: high expression (signal intensity >1,000)
in target tissue and low expression (signal intensity <200)
in nontarget tissues. Using these criteria and combining
data from expression array experiments as well as GNF
SymAtlas database verification, we identified six saliva-
targeted genes and 15 blood-targeted genes that were highly
expressed only in target tissues (or respective organs) but
not, or nearly not, in the nontarget tissues (Electronic
Supplementary Material Figure S1a, S1b, S1c).
RT-PCR confirmation of tissue-specific markers
To confirm the microarray results, real-time PCR experi-
ments were designed for the 21 best candidate markers
selected from array hybridizations and database searches
and performed using RNA extracted from aged blood and
saliva stains, also providing a method suitable for forensic
applications. In agreement with the array results, all 21
markers analyzed showed good amplification in the target
tissue but no or only marginally detectable amplification in
the nontarget tissue (Fig. 1a–c). Among the candidate
markers, only the PPL gene that was targeted for saliva
demonstrated significant expression overlap with blood and
therefore was excluded from further experiments. Our
results demonstrate that, irrespective of the stain storage
time, sufficient RT-PCR amplification was observed in all
samples, even in the samples from the longest storage time
tested (180 days), indicating marker stability over long
periods of sample storage time. The only exception was the
CCR2 gene for which no amplification was detected in the
blood stains stored for 180 days and was therefore
excluded from further analyses. A plausible explanation
for this peculiarity could be the location of the
PCR-amplified region, which is more than 1 kb distant
from the 3′ end of the mRNA because of the very long
untranslated region of CCR2. Apparently, the degree of
degradation of the CCR2 mRNA after 180 days of
sample storage was too high to allow its efficient reverse
transcription using the oligo(dT) method that targets the
3′end of the molecule. This observation highlights the
necessity to design PCR primers for the most 3′-proximal
part of the mRNA molecule for successful amplification
of cDNA fragments in degraded samples.
Expression of the candidate markers in other body fluids
For additional confirmation of the tissue-specificity, we
tested by RT-PCR the expression patterns of our candidate
RNA markers in other body fluids that might be observed
in a forensic case, i.e., vaginal secretion and semen.
According to the GNF SymAtlas database, all our markers
targeted for blood and saliva are not expressed in testis nor
in uterus tissues. In agreement, our dedicated RT-PCR
experiments revealed that two of the saliva-targeted mRNA
markers (SPRR3 and SPRR1A) show no detectable
expression in semen (after 50 RT-PCR cycles), and the
remaining three (KRT4, KRT6A, and KRT13) show vast
overexpression in saliva compared to semen (ddCt>15,
Fig. 2a), keeping with the assumption of high saliva
specificity of the five proposed mRNA markers. SPRR1A
and SPRR3 genes both encode cornified envelope precursor
proteins and are predominantly expressed in oral and
esophageal epithelia, where they are strictly linked to
keratinocyte terminal differentiation [27]. Keratins 4, 6A,
and 13 are known as one of the major structural proteins of
oral mucosa [28, 29].
For the 14 blood-targeted genes, we observed no
detectable amplification in semen for nine genes (CASP1,
AMICA1, C1QR1, ALOX5AP, AQP9, C5R1, NCF2,
MNDA, ARHGAP26), keeping with the assumption of
high blood specificity of the respective mRNA markers.
These genes encode the proteins with important functions
in different types of blood cells. They are known to be
highly or even specifically expressed in peripheral leuko-
cytes (AQP9, NCF2, CASP1, C5R1, C1QR1, ALOX5AP
[30–35]) and myelocytes or hematopoietic cells (MNDA,
ARHGAP26, AMICA1 [36–38] ) .H o w e v e r ,f i v eg e n e s
demonstrated only slightly differential or even comparable
expression in blood and semen (CD36, CCR1, PF4, BIN2,
and ALOX5), not expected given the information provided
by the GNF database, and were therefore excluded from the
final list of blood-specific markers. Thus, our microarray-
based genome-wide approach to find tissue-specific mRNA
markers identified the genes that are functionally relevant
for the target tissues.
Furthermore, and not surprisingly, RT-PCR of all saliva-
and blood-targeted markers in samples from vaginal
secretion revealed gene expression at a level comparable
to that in blood and saliva samples (Fig. 2b). The natural
occurrence of blood cells in vaginal secretion most likely
explains the expression of our blood-targeted markers in
vaginal secretion, whereas the high biochemical and
histological similarity of oral and vaginal epithelia [40]
makes the similarity of gene expression patterns between
138 Int J Legal Med (2008) 122:135–142Fig. 1 a, b RT-PCR results for
blood-targeted genes in blood
and saliva stains. c RT-PCR
results for saliva-targeted genes
in saliva and blood stains. Genes
were selected based on expres-
sion microarray results and GNF
SymAtlas database. Expression
values for each time point were
averaged across three male and
three female RNA samples; no
gender-specific expression dif-
ferences were detected (t test p<
0.05). B indicates blood; S indi-
cates saliva; samples were pro-
cessed after complete drying of
blood and saliva at 0, 21, 57,
and 180 days, respectively
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markers previously claimed to be useful for the identifica-
tion of vaginal secretion such as HBD-1 [18] and MUC4
[18, 19] are known to be abundant also in oral epithelial
cells and the salivary transcriptome [41–43]. Furthermore,
Nussbaumer et al. [19] ruled out the potential to differentiate
saliva and vaginal secretion using solely MUC4. Our results,
together with previous findings, suggest that establishing
mRNA markers expressed exclusively in vaginal secretion
could be a challenging if not impossible task.
Comparison with previously suggested mRNA markers
Interestingly, tissue-specific genes, as identified here, do
not overlap with the ones previously suggested for blood
and saliva stain identification [18, 19]. This could be
explained by the experimental setup and the systematic (but
not ad hoc) approach of this study, namely, the degraded
biological material analysed and the Affymetrix microarray
platform applied. In contrast to previous studies, we
restricted our marker ascertainment to those genes, which
retained structural mRNA integrity during the stain dry-out
process as well as the subsequent long-term storage of
180 days. This allows future application of detection of
these markers in forensic stains of unknown age, at least up
to an age of 6 months, but expectedly longer. Furthermore,
our saliva-specific candidate genes were derived from
mouth and pharynx epithelial cells, unlike the previously
suggested STATH and HTN3 genes that are expressed in
the salivary gland [18]. Secreted mRNAs that are abundant
in fresh saliva are more prone to fast degradation by
extracellular RNAses [39]; they are therefore not expected
to be present in dried stains, explaining why they were not
detected by the relatively low-sensitive microarray hybrid-
ization method used in this study. The SPTB and PBGD
genes, previously proposed as blood-specific markers [18],
Fig. 2 a RT-PCR for saliva and
blood-targeted genes in semen
stains. b RT-PCR for saliva and
blood targeted in vaginal secre-
tion stains. Delta Ct (dCt) values
were calculated as follows:
dCt=Ct (candidate gene)−Ct
(endogenous control, GAPDH
gene). Low dCt values corre-
spond to high expression level
of the specific mRNA. Gray
bars correspond to the samples
from target tissues for selected
genes (either blood or saliva);
black bars correspond to sam-
ples from nontarget tissues
(either vaginal secretion or
semen). Dotted bars represent
the cases were amplification was
not detected after 50 cycles, in
this case, the expression values
were arbitrary set to Ct value of
25 (plot maximum)
140 Int J Legal Med (2008) 122:135–142do not demonstrate any overexpression relative to other
tissues in whole blood according to the GNF SymAtlas
database (data not shown).
Conclusions
In summary, whole-genome expression analysis in time-
wise degraded samples from blood and saliva stains in
combination with RT-PCR verification of various forensi-
cally relevant body fluids has resulted in the identification
of stable tissue-specific mRNA markers from five genes for
saliva (SPRR3, SPRR1A, KRT4, KRT6A, and KRT13) and
nine genes for whole blood (CASP1, AMICA1, C1QR1,
ALOX5AP, AQP9, C5R1, NCF2, MNDA, and ARH-
GAP26). For the first time, mRNA markers were ascer-
tained considering almost the entire human transcriptome
and based on experimental data of genome-wide gene
expression as well as considering the degradation stability
of mRNAs. We could demonstrate that the candidate genes
identified here provide informative mRNA markers for
blood and saliva identification for stains up to 180 days of
age. We would like to propose their application in forensic
case work (with the potential practical limitation of
coamplification in vaginal secret) for stains of at least
6 months of age. However, we expect that the proposed
mRNA markers will successfully identify older blood and
saliva stains (respective experiments are currently in
progress). Finally, we would like to remark that tissue
identification in forensics should be performed in a
reciprocal way; so that a tissue is identified because of the
presence of markers specific for the relevant tissue together
with the absence of markers specific for all other tissues in
question. Clearly, more research should be dedicated
towards finding the most suitable markers for tissue
identification in forensics.
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